2023
Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration
Gordon A, Saxon A, Kertesz S, Wyse J, Manhapra A, Lin L, Chen W, Hansen J, Pinnell D, Huynh T, Baylis J, Cunningham F, Ghitza U, Bart G, Yu H, Sauer B. Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration. Drug And Alcohol Dependence 2023, 248: 109902. PMID: 37196572, PMCID: PMC10875624, DOI: 10.1016/j.drugalcdep.2023.109902.Peer-Reviewed Original ResearchConceptsOpioid use disorderVeterans Health AdministrationUse disordersHealth AdministrationOpioid use disorder treatmentHalf of patientsOpen cohort studyRetention of patientsCourse of careUse disorder treatmentLarge healthcare systemCohort studyMedian durationPatient characteristicsPatient demographicsDaily doseMedication treatmentBuprenorphine useClinical dataWhite racePatientsProportion daysDisorder treatmentMultiple coursesHealthcare system
2019
Prescribing, Prescription Monitoring, and Health Policy
Gordon A, Cochran G, Smid M, Manhapra A, Kertesz S. Prescribing, Prescription Monitoring, and Health Policy. Current Clinical Psychiatry 2019, 223-238. DOI: 10.1007/978-3-030-16257-3_11.Peer-Reviewed Original ResearchOpioid use disorderPrescription drug monitoring programsUse disordersOpioid prescribingOpioid prescriptionsOpioid useOpioid misuseClinical interventionsOpioid-related harmsPrescription opioid useDrug monitoring programsOpioid-related morbidityOpioid addiction epidemicUnited States CentersTreatment of personsPrescribing opioidsChronic painIllicit opioidsCDC guidelinesMedication treatmentPrescription monitoringOpioid epidemicHealth of communitiesAddiction epidemicDisease control